| Literature DB >> 35873163 |
Luís Felipe Costa Ramos1, Michele Martins1, Jimmy Rodriguez Murillo2, Gilberto Barbosa Domont1, Danielle Maria Perpétua de Oliveira1, Fábio César Sousa Nogueira1, Rafael Maciel-de-Freitas3,4, Magno Junqueira1.
Abstract
Zika is a vector-borne disease caused by an arbovirus (ZIKV) and overwhelmingly transmitted by Ae. aegypti. This disease is linked to adverse fetal outcomes, mostly microcephaly in newborns, and other clinical aspects such as acute febrile illness and neurologic complications, for example, Guillain-Barré syndrome. One of the most promising strategies to mitigate arbovirus transmission involves releasing Ae. aegypti mosquitoes carrying the maternally inherited endosymbiont bacteria Wolbachia pipientis. The presence of Wolbachia is associated with a reduced susceptibility to arboviruses and a fitness cost in mosquito life-history traits such as fecundity and fertility. However, the mechanisms by which Wolbachia influences metabolic pathways leading to differences in egg production remains poorly known. To investigate the impact of coinfections on the reproductive tract of the mosquito, we applied an isobaric labeling-based quantitative proteomic strategy to investigate the influence of Wolbachia wMel and ZIKV infection in Ae. aegypti ovaries. To the best of our knowledge, this is the most complete proteome of Ae. aegypti ovaries reported so far, with a total of 3913 proteins identified, were also able to quantify 1044 Wolbachia proteins in complex sample tissue of Ae. aegypti ovary. Furthermore, from a total of 480 mosquito proteins modulated in our study, we discuss proteins and pathways altered in Ae. aegypti during ZIKV infections, Wolbachia infections, coinfection Wolbachia/ZIKV, and compared with no infection, focusing on immune and reproductive aspects of Ae. aegypti. The modified aspects mainly were related to the immune priming enhancement by Wolbachia presence and the modulation of the Juvenile Hormone pathway caused by both microorganism's infection.Entities:
Keywords: Aedes aegypti; Wolbachia; Zika virus; immune defense; juvenile hormone; proteome; quantitative
Mesh:
Year: 2022 PMID: 35873163 PMCID: PMC9302590 DOI: 10.3389/fcimb.2022.900608
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Figure 1Workflow method and main protein identification results. (A) Mosquitoes infection protocol in which mosquitoes infected and non-infected with Wolbachia were captured and half were infected with ZIKV in vitro; ovaries were extracted after 14 days. (B) Sample preparation for proteomics, using trypsin enzyme for digestion step and peptides labeling was performed with iTRAQ-4plex and mixed in a 1:1:1:1 ratio; labeled peptides were fractionated offline using HILIC chromatography; samples were named depending on its infection condition: A - non-infected mosquitoes; W - Wolbachia infected; Z - ZIKV infected. (C, D) The pool of fractions was analyzed by nLC–MS/MS in Q-Exactive Plus mass spectrometer and the fragmentation scheme shows reporter ions at the low m/z region used for relative quantification of the peptides/proteins. (E) Data analysis was first performed with Proteome Discoverer 2.4 software using Ae. aegypti, Wolbachia and ZIKV peptides database and after statistical and bioinformatics analysis was done in software Perseus using VectorBase to enrich proteins differentially regulated for GO and KEGG. (F) Summary proteins identification result, where a total of 4931 proteins and 33,529 peptides were identified, including the three organisms.
Figure 2Quantitative proteomics data. (A) Abundance chart of the three replicates of identified Wolbachia pipientis proteins. High expression is observed in the W and ZW samples, showing that it is possible to compare the expression of proteins by the relative quantification of the iTRAQ; (B) Volcano plot of Wolbachia proteins comparing WZ/W. The red dots represent upregulated proteins; (C) Heatmap of all Ae aegypti identified proteins that were upregulated (red) or downregulated (blue) during the comparison between control, monoinfected, and coinfected samples; (D) Mainly upregulated pathways statistically relevant in each condition comparison. (E) Mainly downregulated pathways statistically relevant in each condition comparison.
Wolbachia proteins with significant differences in abundance between W and WZ.
| Uniprot | Proteins | p-value | Fold changes W/WZ | Biological Process | Cellular Component | Molecular Function |
|---|---|---|---|---|---|---|
| Q73IW9 | Bifunctional DNA-directed RNA polymerasesubunitbeta-beta' | 0,000444461 | 0,411035542 | metabolic process | catalytic activity;DNA binding | |
| Q73H30 | Porin 4 domain-containing protein | 0,012058539 | 0,595912427 | |||
| A0A5R9MDU9 | ATP-dependentchaperoneClpB | 0,002478004 | ||||
| A0A5R9MBZ5 | Insulinase family protein | 0,04901528 | 0,579255197 | |||
| Q73G77 | Outer membrane protein assembly factor BamA | 0,018472215 | 0,527555786 | cell organization and biogenesis | membrane | |
| Q73HD5 | Cytoplasmic incompatibility factor CifA | 779842E-05 | 0,560087056 | |||
| Q73H52 | Hypothetical protein | 0,024988487 | 0,51835011 | membrane | ||
| AQA098ASI2 | Pyruvate, phosphatedikinase | 1,05157E-05 | 0,579445156 | metabolic process | catalyticactivity;metal ion binding;nucleotide binding | |
| A0AO98ASBS | Ribosome-recycling factor | 0,021748863 | 0,503098093 | cell organization and biogenesis;metabolicprocess | cytoplasm | RNA binding |
| Q73HB3 | TranscriptionelongationfactorGreA | 0,034470463 | 0,440927891 | metabolic process;regulation of biological process | DNAbinding;proteinbinding;RNAbinding | |
| Q4ECB1 | OmpA family protein | 0,001739336 | 0,485774855 | membrane | ||
| Q73HQ7 | Surface antigen, Wspparalog | 0,011469895 | 0,62249352 | |||
| A0A09SAS15 | MgtEintracelularN domain | 0,000908949 | 0,704846358 | |||
| M9WUJ8 | SOS ribosomal protein L3 | 0,026263219 | 0,67093336 | metabolic process | ribosome | RNAbinding;structural molecule activity |
| C0F8V0 | Phosphatidylserine decarboxylase proenzyme | 0,045093524 | 0,427720959 | metabolic process | membrane | catalytic activity |
| Q4EAL9 | 50SribosomalproteinL1 | 0,034407904 | 0,666474541 | metabolic process;regulation of biological process | ribosome | RNAbinding;structural molecule activity |
| Q73HX6 | Aspartate-tRNA(Asp/Asn) ligase | 0,005344562 | 0,52587834 | metabolic process | cytoplasm | catalytic activity;nucleotide binding |
| Q73FS0 | ATP-dependent zinc metalloprotease FtsH | 0,010445494 | 0,585365863 | cell division; metabolic process;response to | membrane | catalyticactivity;rnetal ion binding;nucleotide binding |
| A0A5B9K3B3 | SOS ribosomal protein L5 | 0,039504806 | 0,505903393 | |||
| A0AQ98ATK8 | Citrate synthase | 0,011127846 | 0,515264518 | metabolic process | cytoplasm | catalytic activity |
| C0F9Z9 | Protein HfIC | 0,031868241 | 0,403411331 | regulation of biological process | membrane | |
| A0A2A4IJ89 | Inositol monophosphatase | 0,005206978 | 0,597804797 | |||
| Q73HW7 | Isoleucine-tRNA ligase | 0,00713402 | 0,427841423 | metabolic process;regulation of biological process | cytoplasm | catalytic activity;metal ion binding;nucleotidebinding;RNA |
| AOA060Q1B9 | Iron(lll) transportsystem substrate-binding protein | 0,023415784 | 0,589204769 | transport | metal ion blnding;transporter activity | |
| Q73GT7 | Hypothetical protein | 0,01601564 | 0,452984557 | |||
| A0A1V2N3U3 | Leucine-tRNA ligase | 1.26546E-05 | 0,529255411 | metabolic process;regulation of biological process | cytoplasm | catalytic activity;nucleotide binding |
| Q73GS5 | Type IV secretion system protein VirB6 | 0,00857789 | 0,61741491 | transport | membrane | |
| A0A2A4IGS0 | ATPsynthaseganmachain | 0,042213912 | 0,574342268 | |||
| A0AQ98ARZ7 | Fido domain-containing protein | 0,011555349 | ||||
| A0A5R9MDS2 | Folate-bindingproteinYgfZ | 0,042029907 | 0,7052091 | |||
| C0F8P8 | MalonylCoA-acylcarrierproteintransacylase | 0,005819131 | 0,598572843 | metabolic process | catalytic activity | |
| A0A225X8G2 | DNA mismatch repair protein MutS | 0,012269948 | 0,422355559 | |||
| Q4ECU7 | NADH-quinoneoxidoreductasesubunitC | 0,025713881 | 0,631272563 | metabolic process;transport | membrane | catalytic activity |
| M9WVR3 | ReplicativeDNA helicase | 0,015991817 | 0,575902317 | metabolic process | catalyticactivity;DNAbinding;nucleotide binding | |
| A0A2A4IK13 | Magnesium transporter MgtE | 0,049013747 | 0,435309293 | |||
| B7TW57 | RmlD_sub_bind domain-containing protein (Fragment) | 0,034994832 | 0,592799831 | |||
| I7IU09 | Putative pyruvate, phosphate dikinase regulator/ protein | 0,004012121 | 0,545064889 | metabolic process | catalytic activity;nucleotide binding | |
| B5Y8B7 | Ankyrinrepeatdomainprotein | 0,012561568 | 0,38957124 | nucleotide binding;protein binding | ||
| A0AO98AU34 | Peptidyl-prolyl cis-trans isomerase | 0,019230457 | 0,562841529 | metabolic process | membrane | catalytic activity |
Figure 3Identification and modulation of proteins that participate in the JH pathway, composed of the mevalonate pathway (early step), represented in gray, and juvenile hormone branch (last step), represented in blue, and juvenile hormone branch (last step), represented in red (pathway adapted from Nouzova et al., 2011). Enzymes colored in green were identified in Ae. aegypti proteome in this work, and enzymes colored in purple were identified and quantified as modulated during ZIKV or Wolbachia infection. Mevalonate kinase and farnesol dehydrogenase were downregulated in Wolbachia infection and farnesol dehydrogenase was upregulated in ZIKV infection, as represented in graphs containing each condition and the respective fold change of each modulated protein.
Figure 4Ontology network of summarized enriched biological processes related to mevalonate kinase and farnesol dehydrogenase. The size of the bubble corresponds to the LogSize value for the GO Term. The overview and the interaction network were obtained in software revigo and cytoscape 3.8.0, respectively.